Nomograms in oncology: more than meets the eye
2015 · The Lancet Oncology · 3,355 citations
https://doi.org/10.1016/s1470-2045(14)71116-7
V
Vinod P. Balachandran
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
436
Papers
16.6K
Citations
51
h-index
129
i10-index
Vinod P. Balachandran is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cholangiocarcinoma and Gallbladder Cancer Studies & Cancer Genomics and Diagnostics. The author has an h-index of 51, co-authored 371 publications.
ORCID: 0000-0002-2956-223XPapers by this author
worksPersonalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
2023 · Nature · 1,154 citations
https://doi.org/10.1038/s41586-023-06063-y
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
2017 · Nature · 647 citations
https://doi.org/10.1038/nature24473
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
2021 · Nature Communications · 440 citations
https://doi.org/10.1038/s41467-021-20935-9
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
2025 · Nature · 187 citations
https://doi.org/10.1038/s41586-024-08508-4
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
2022 · Nature · 184 citations
https://doi.org/10.1038/s41586-022-04735-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat